J P Ortonne
Overview
Explore the profile of J P Ortonne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
497
Citations
3363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taieb A, Ortonne J, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone M, et al.
Br J Dermatol
. 2014 Sep;
172(4):1103-10.
PMID: 25228137
Background: Few therapeutic alternatives currently exist in the treatment of papulopustular rosacea (PPR). Objectives: To demonstrate superiority of once-daily ivermectin 1% cream (IVM 1%) once daily vs. twice-daily metronidazole (MTZ...
2.
Gilet H, Roborel de Climens A, Arnould B, Bachelez H, Bagot M, Beaulieu P, et al.
J Eur Acad Dermatol Venereol
. 2014 Jul;
29(3):498-506.
PMID: 25059687
Background: To date, there is no global consensus on the definition of the severity of psoriasis. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire has recently...
3.
Chuah S, Tsilika K, Chiaverini C, Fontas E, Ortonne J, Lacour J, et al.
Br J Dermatol
. 2014 Jun;
172(1):88-93.
PMID: 24931364
Background: Acral naevi are a peculiar subtype of naevus with specific dermoscopic patterns. Little is known about congenital melanocytic naevi affecting acral volar skin in children. Objectives: To determine the...
4.
Montaudie H, Albert-Sabonnadiere C, Acquacalda E, Fontas E, Danre A, Roux C, et al.
J Eur Acad Dermatol Venereol
. 2013 Aug;
28(9):1186-91.
PMID: 23981008
Background: Several markers of comorbidities and cardiovascular (CV) risk are disturbed in moderate to severe psoriasis (PsO). The effect of systemic treatments of psoriasis on these markers remains poorly understood....
5.
Tan J, Blume-Peytavi U, Ortonne J, Wilhelm K, Marticou L, Baltas E, et al.
Br J Dermatol
. 2013 Apr;
169(3):555-62.
PMID: 23600367
Background: Few studies have evaluated differences between rosacea subtypes in epidemiological associations and clinical features. The natural history of rosacea is unknown and progression between subtypes has been implied but...
6.
Ortonne J
Ann Dermatol Venereol
. 2013 Mar;
139 Suppl 4:S125-9.
PMID: 23522626
The varieties of normal skin color in humans range from people of "no color" (pale white) to "people of color" (light brown, dark brown, and black). Skin color is a...
7.
Lahfa M, Bulai-Livideanu C, Baran R, Ortonne J, Richert B, Tosti A, et al.
Dermatology
. 2013 Mar;
226(1):5-12.
PMID: 23467055
Background: Toenail onychomycosis is highly prevalent, with 14-28% of people aged 60 or over suffering from the disease. Use of a topical antifungal alone in toenail onychomycosis is associated with...
8.
Boukari F, Lacour J, Ortonne J, Bahadoran P, Passeron T
J Eur Acad Dermatol Venereol
. 2012 Nov;
28(3):374-7.
PMID: 23167541
Background: Blanching creams are used to depigment and to achieve uniform skin tone in widespread vitiligo. Length of the treatment and side-effects strongly limit their use in common practice. Objectives:...
9.
Ortonne J, Paul C, Berardesca E, Marino V, Gallo G, Brault Y, et al.
Br J Dermatol
. 2012 Sep;
168(5):1080-7.
PMID: 23013207
Background: Nail psoriasis is common in patients with psoriasis and can seriously affect their quality of life. Current treatments are limited and there is no standard course of therapy. Objectives:...
10.
Castela E, Archier E, Devaux S, Gallini A, Aractingi S, Cribier B, et al.
J Eur Acad Dermatol Venereol
. 2012 Apr;
26 Suppl 3:47-51.
PMID: 22512680
Background: Topical steroids have been used for more than 50 years in mild-to-moderate plaque psoriasis and carry a theoretical risk of adverse events. Objectives: The aim of this systematic literature...